Prometheus Laboratories Inc announces the nationwide commercial launch of three new cancer diagnostic products, each based on recently developed, highly sensitive microRNA technology.
Read More
AperioApplied Spectral ImagingAtherotechAureon LaboratoriesBiolmageneMilestone MedicalNovovision IncThermo Fisher ScientificVentana Medical Systems
Read MoreCoriell Institute for Medical Research announces that Ohio State University Medical Center will join the Coriell Personalized Medicine Collaborative research study and examine the utility of incorporating genome information into patients primary healthcare at the medical center.
Read MoreGen-Probe Incorporated (NASDAQ: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Read MoreCancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.
Read More